1. Home
  2. SMID vs NTHI Comparison

SMID vs NTHI Comparison

Compare SMID & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

SELL

Current Price

$24.68

Market Cap

117.7M

Sector

Industrials

ML Signal

SELL

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

SELL

Current Price

$3.17

Market Cap

106.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SMID
NTHI
Founded
1960
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.7M
106.0M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
SMID
NTHI
Price
$24.68
$3.17
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
6.7K
★ 125.2K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.76
N/A
EPS
★ 0.51
N/A
Revenue
★ $93,446,000.00
$39,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$46.96
★ N/A
Revenue Growth
★ 19.03
N/A
52 Week Low
$20.89
$2.50
52 Week High
$40.00
$12.00

Technical Indicators

Market Signals
Indicator
SMID
NTHI
Relative Strength Index (RSI) 61.71 49.88
Support Level $23.51 $3.03
Resistance Level $25.25 $3.66
Average True Range (ATR) 0.66 0.28
MACD 0.36 0.07
Stochastic Oscillator 88.96 42.71

Price Performance

Historical Comparison
SMID
NTHI

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: